Treatment of hepatitis B virus-associated glomerulonephritis: A meta-analysis

Table 1 Characteristics of 9 included studies

Study	Country or region	Patients		Study design
		Gender	Age (yr)
Lin[16], 1995	Taiwan, China	29M, 11F	6.2 ± 2.4	RCT (3 score)
Bhimma et al[17], 2002	South Africa	34M, 5F	8.7, 9.2	Cohort study
Lai et al[18], 1991	Hong Kong, China	14M, 2F	27.2 ± 6.2	Cohort study
Tang et al[19], 2005	Hong Kong, China	14M, 8F	48.3 ± 12.8, 43.1 ± 22.8	Cohort study
Panomsak et al[20], 2006	Thailand	14M, 10F	39.8	Cohort study
Yang et al[21], 2003	Wenzhou, China	28M, 5F	8.01 ± 1.23	Cohort study
Lai et al[22], 1990	Hong Kong, China	10M, 5F	22.8 ± 14.4, 17.2 ± 8.2	Cohort study
Ozdamar et al[23], 2003	Turkey	11M, 3F	10	Cohort study
Peña et al[24], 2001	Spain	11M, 1F	4.52 ± 2.34	Cohort study

RCT: Randomized controlled trial.